NBP258582PE

Novus Biologicals™ CHD8 Recombinant Protein Antigen

Manufacturer: Novus Biologicals™

Select a Size

Pack Size SKU Availability Price
Each of 1 NBP258582PE-Each-of-1 In Stock ₹ 31,372.50

NBP258582PE - Each of 1

₹ 31,372.50

In Stock

Quantity

1

Base Price: ₹ 31,372.50

GST (18%): ₹ 5,647.05

Total Price: ₹ 37,019.55

Gene ID (Entrez)

57680

Common Name

CHD8 Recombinant Protein Antigen

Formulation

PBS and 1M Urea, pH 7.4.

Gene Alias

ATP-dependent helicase CHD8, CHD-8, chromodomain helicase DNA binding protein 8, DKFZp686N17164, duplin, EC 3.6.1, EC 3.6.1.7, EC 3.6.4.12, Helicase with SNF2 domain 1chromodomain-helicase-DNA-binding protein 8, HELSNF1, KIAA1564axis duplication inhibitor

Label Type

Unlabeled

Quantity

100μL

Source

E.coli

Purification Method

>80% by SDS-PAGE and Coomassie blue staining

Content And Storage

Store at −20°C. Avoid freeze-thaw cycles.

For Use With (Application)

Blocking/Neutralizing, Control

Gene Symbol

CHD8

Product Type

Recombinant Protein Antigen

Regulatory Status

RUO

Specific Reactivity

This recombinant antigen is only intended to be used as a blocking agent to confirm antibody specificity with the corresponding antibody, catalog number NBP2-51764. It is purified by IMAC chromatography, and the expected concentration is greater than 0.5 mg/ml

Related Products

Img

Novus Biologicals™

NBP258487PE

--

Img

Novus Biologicals™

NBP258609PE

--

Img

Novus Biologicals™

NBP258366PE

--

Img

Novus Biologicals™

NBP258711PE

--

Img

Novus Biologicals™

NBP258755PE

--

Img

Novus Biologicals™

NBP258749PE

--

Img

Novus Biologicals™

NBP258835PE

--

Img

Novus Biologicals™

NBP258740PE

--

Description

  • A recombinant protein antigen with a N-terminal His6-ABP tag corresponding to human CHD8
  • Source: E.coli Amino Acid Sequence: PEFAVDPRFLAYMEDRRKQKWQRCKKNNKAELNCLGMEPVQTANSRNGKKGHHTETVFNRVLPGPIAPESSKKRARRMRPDLSKMMALMQGGSTGSLSLHNTFQHSSSGLQSVSSLGHSSATSASLPFMPFVMGGAPSSPHVD The CHD8 Recombinant Protein Antigen is derived from E
  • coli
  • The CHD8 Recombinant Protein Antigen has been validated for the following applications: Antibody Competition.